PharmaShares Partners With Syntax and Raptor Trading to Launch Innovative Pharmaceutical Indices
PharmaShares Advisors LLC has partnered with Syntax LLC to develop the Syntax PharmaShares AbbVie - Humira Paired Index, the first index that tracks individual commercialized pharmaceutical products distinct from the overall performance of a sponsoring pharmaceutical company’s stock.
- PharmaShares Advisors LLC has partnered with Syntax LLC to develop the Syntax PharmaShares AbbVie - Humira Paired Index, the first index that tracks individual commercialized pharmaceutical products distinct from the overall performance of a sponsoring pharmaceutical company’s stock.
- “As the first indices of their kind, the PharmaShares index series illustrate the continuing opportunity for innovation in indexing,” said Patrick Shaddow, CEO of Syntax.
- “We’re excited to partner with PharmaShares to develop index solutions that can form the foundation for innovative investment products.”
Each index in the Syntax PharmaShares Stock & Lead Product Index Series will focus on a single pharmaceutical company and its lead product. - PharmaShares and Syntax have signed a collaboration agreement to publish multiple single stock / drug indices based upon this theme.